Picture of Shenzhen Hepalink Pharmaceutical Co logo

9989 Shenzhen Hepalink Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Shenzhen Hepalink Pharmaceutical to invest in Canada's Resverlogix Corp

Oct 13 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd 
 002399.SZ  
    * Says it plans to invest up to C$87 million  ($69.75 
million) in Canada's Resverlogix Corp  RVX.TO  
 
 
    Source text in Chinese: http://bit.ly/2i9ZrGw 
    Further company coverage:  002399.SZ  
 
($1 = 1.2473 Canadian dollars) 
 
 (Reporting by Hong Kong newsroom) 
 ((hongkong.newsroom@thomsonreuters.com; (852) 2843-6441; 
Reuters Messaging: chyenyee.lee.reuters.com@reuters.net))

Recent news on Shenzhen Hepalink Pharmaceutical Co

See all news